FY2026 Q3 revenue decreased year-over-year, but ARPU improved due to expansion of the prescription-history generation AI option. Full-year forecast was revised downward, while the annual dividend of 23 yen was maintained. Absorption-type mergers of two subsidiaries are planned for January 2027. By segment, dispensing and medical systems were affected by the waning of welfare-administration related demand, while nursing care\/welfare recovered due to price revision effects.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4820","jir_company_name":"EM Systems Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4820-20261113-02.pdf","jir_short_summary":"FY2026 Q3 revenue decreased year-over-year, but ARPU improved due to expansion of the prescription-history generation AI option. Full-year forecast was revised downward, while the annual dividend of 23 yen was maintained. Absorption-type mergers of two subsidiaries are planned for January 2027. By segment, dispensing and medical systems were affected by the waning of welfare-administration related demand, while nursing care\/welfare recovered due to price revision effects.","jir_summary":"### Performance Overview\nIn FY2026 Q3, revenue and profits declined year-over-year due to the normalization of welfare-administration related demand. However, ARPU improved year-over-year driven by expansion of the prescription-history generation AI option in the dispensing segment, a revision of the pricing structure, and transition to a shared sales structure with Good Cycle System. By segment, there was a mix of decreased upfront sales and increased recurring (stock) sales. Recognition of gains on sale of investment securities narrowed the year-over-year decline in quarterly net income compared with the interim period. Although the full-year forecast was revised downward, the company maintains a payout ratio above 100% and kept the annual dividend at 23 yen.\n\n### Initiatives and Outlook for Next Fiscal Year\nThe company will conduct absorption-type mergers of two subsidiaries (EM Technology Laboratory and Good Cycle System) to integrate development, planning, sales, and service. Through organizational restructuring, the group aims to improve operating efficiency and eliminate duplicated costs, while continuing to invest in AI, cybersecurity, and medical DX. From next fiscal year onward, the company intends to improve profitability in each business and redirect capacity toward cross-group growth investments.","jir_financial_highlights":"Revenue: 15,573 (Year-over-Year -14.0%)\nEBITDA: 2,250 (Year-over-Year -45.9%)\nOperating Income: 1,587 (Year-over-Year -52.8%)\nNet Income: 1,722 (Year-over-Year -28.3%)\nAnnual Dividend: 23 yen (maintained)","jir_category":"","jir_hashtags":"#EMSystems, #Earnings, #MediumTermManagementPlan, #AI, #MedicalDX","jir_key_figures":"Revenue: 15,573 million yen (FY2026 Q3 results, Year-over-Year -14.0%)\nEBITDA: 2,250 million yen (FY2026 Q3 results, Year-over-Year -45.9%)\nNet Income: 1,722 million yen (FY2026 Q3 results, Year-over-Year -28.3%)","jir_meta_title":"EM Systems Co., Ltd. Earnings Presentation | FY2026 Q3","jir_meta_description":"Key points from EM Systems Co., Ltd.'s FY2026 Q3 earnings presentation: revenue and profit trends, segment developments, next fiscal year strategy, and dividend policy summarized.","jir_og_title":"EM Systems Co., Ltd. Earnings Presentation: FY2026 Q3","jir_og_description":"Overview of FY2026 Q3 performance and next fiscal year policy. Introduces ARPU improvement measures and planned subsidiary absorption-type mergers.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025 Q3\\\",\\\"FY2026 Q3\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[18114,15573]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2025 Q3\\\",\\\"FY2026 Q3\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[3363,1587]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue Breakdown\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Dispensing Systems\\\",\\\"Medical Systems\\\",\\\"Nursing Care\/Welfare Systems\\\",\\\"Other\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"FY2026 Q3\\\",\\\"data\\\":[12289,1902,713,782]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Margin & Net Margin\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2026 Q3\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Margin\\\",\\\"data\\\":[?]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Full-Year Forecast vs. Results\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"table\\\",\\\"data\\\":[{\\\"item\\\":\\\"Revenue\\\",\\\"actual\\\":221? ,\\\"forecast\\\":227?}]}\"}]","ir_related_company":17294,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-152994","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n